BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15090155)

  • 1. Zebrafish: a preclinical model for drug screening.
    Parng C; Seng WL; Semino C; McGrath P
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):41-8. PubMed ID: 15090155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
    Seng WL; Eng K; Lee J; McGrath P
    Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos.
    Tucker B; Lardelli M
    Zebrafish; 2007; 4(2):113-6. PubMed ID: 18041929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
    Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
    Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds.
    Ali S; Champagne DL; Richardson MK
    Behav Brain Res; 2012 Mar; 228(2):272-83. PubMed ID: 22138507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish apoptosis assays for drug discovery.
    Parng C; Anderson N; Ton C; McGrath P
    Methods Cell Biol; 2004; 76():75-85. PubMed ID: 15602872
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo zebrafish assays for analyzing drug toxicity.
    Raldúa D; Piña B
    Expert Opin Drug Metab Toxicol; 2014 May; 10(5):685-97. PubMed ID: 24617455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule screening in the zebrafish.
    Murphey RD; Zon LI
    Methods; 2006 Jul; 39(3):255-61. PubMed ID: 16877005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of zebrafish apoptosis assays for preclinical drug discovery.
    McGrath P; Seng WL
    Expert Opin Drug Discov; 2013 Oct; 8(10):1191-202. PubMed ID: 23964640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish as a model for developmental neurotoxicity testing.
    Ton C; Lin Y; Willett C
    Birth Defects Res A Clin Mol Teratol; 2006 Jul; 76(7):553-67. PubMed ID: 16933308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos.
    McAleer MF; Duffy KT; Davidson WR; Kari G; Dicker AP; Rodeck U; Wickstrom E
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):546-51. PubMed ID: 16904844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
    Nicoli S; Ribatti D; Cotelli F; Presta M
    Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo.
    Selderslaghs IW; Van Rompay AR; De Coen W; Witters HE
    Reprod Toxicol; 2009 Nov; 28(3):308-20. PubMed ID: 19447169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zebrafish models for assessing developmental and reproductive toxicity.
    He JH; Gao JM; Huang CJ; Li CQ
    Neurotoxicol Teratol; 2014; 42():35-42. PubMed ID: 24503215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling.
    Driessen M; Kienhuis AS; Pennings JL; Pronk TE; van de Brandhof EJ; Roodbergen M; Spaink HP; van de Water B; van der Ven LT
    Arch Toxicol; 2013 May; 87(5):807-23. PubMed ID: 23559145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish embryos and larvae: a new generation of disease models and drug screens.
    Ali S; Champagne DL; Spaink HP; Richardson MK
    Birth Defects Res C Embryo Today; 2011 Jun; 93(2):115-33. PubMed ID: 21671352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals.
    Fraysse B; Mons R; Garric J
    Ecotoxicol Environ Saf; 2006 Feb; 63(2):253-67. PubMed ID: 16677909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay.
    Cross LM; Cook MA; Lin S; Chen JN; Rubinstein AL
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):911-2. PubMed ID: 12740225
    [No Abstract]   [Full Text] [Related]  

  • 19. Protocol development for discovery of angiogenesis inhibitors via automated methods using zebrafish.
    Mauro A; Ng R; Li JY; Guan R; Wang Y; Singh KK; Wen XY
    PLoS One; 2019; 14(11):e0221796. PubMed ID: 31730619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput method for predicting drug effects on gut transit time using larval zebrafish.
    Cassar S; Huang X; Cole T
    J Pharmacol Toxicol Methods; 2015; 76():72-5. PubMed ID: 26311656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.